ok decan so how far away in years terms are prr from completing...

ok decan so how far away in years terms are prr from completing phase 3 trials.i read in your post on the 20/4/09 that you believe 7 years..heres a quote from you and the link..

PRR is about 7 years behind Dendreon at best and where is it going to raise a couple of hundred million dollars when its phase 2 data is not that exciting?

http://www.hotcopper.com.au/post_single.asp?fid=1&tid=877556&msgid=4871232


ok so yesterday both kinetic securities and abn ambro are saying prr are between 2 to 3 years behind dendreons completed phase 3 trials and comercialisation.

so tell me who am i to believe..you or abn ambro or kinetic securities or in fact prr's asx announcements which state they are making an fda ind applicication for phase11b/111 trilals..i have double checked this with prr and yes that is what they are applying for.

heres what abn ambro says..

Prima recently announced that it has commenced discussions with a potential North
American insitutional investment fund. The funds raised will enable a Phase IIb/III Pivotal trial
to be undertaken. Currently the company has commenced its Investigational New Drug
application for the FDA. It is anticipated that the trial could commence in September 2009.
The trial would take approximately two years to complete. Prima would explore partnering
opportunities during this time. An interesting play for investors with a high risk profile.

and the link:http://www.primabiomed.com.au/projects/prodDocuments/ABM%20AMRO%20Morgans%20Healthcare%20Research%20May%2009.pdf


and heres what kinetic securities has to say..

Prima BioMed - holding 50% retrace level
After rallying 1300% in the last 12 months, the price of PRR is resting around the 50% level
of this trading range. Often stocks will form major lows on this 50% level. If PRR can
continue to consolidate and hold above $0.06 in the near future, then the stock could be
positioned to move significantly higher in the future. PRR is approximately 2 – 3 years
behind DNDN, with some positive trials and a FDA approval, PRR has huge potential upside.

and heres the link:http://www.primabiomed.com.au/projects/prodDocuments/Kinectics%20PRR%20Research.pdf


for some strange reason kinetic and abn ambro dont agree with you and for some strange reason i take their word ahead of some unanimous poster on hotcopper..